Patient Safety

Fertility Clinic Error Destroys Embryos and Raises Questions About Medical Accountability in Maryland

September 22, 2025 | Lebowitz & Mzhen

Trust plays a central role in fertility treatment. When a clinic mishandles embryos or makes a preventable error, the impact reaches beyond medical consequences. A recent case involving the destruction of viable embryos has brought renewed attention to how medical professionals handle the profoundly personal and highly sensitive process of in vitro fertilization. If you experienced a similar loss in Maryland, you may have the right to take legal action and hold the responsible parties accountable.

Embryo Loss After Preventable IVF Mistake

A woman undergoing IVF learned that her embryos had been destroyed before transfer due to a critical clinic error. The mistake involved the use of an incorrect storage solution, which rendered the embryos unusable. After months of hormone therapy, physical discomfort, and emotional preparation, her path to parenthood came to an abrupt and devastating halt.

This kind of error is not rare. It often stems from inadequate procedures, poor communication among staff, or outdated safety protocols. The process of preparing and storing embryos requires absolute precision and accuracy. Any lapse can cause permanent harm.

Families place enormous trust in fertility clinics to care for their future. When that trust is broken, the fallout can involve emotional distress, financial loss, and years of lost opportunity. Maryland law acknowledges the severity of this harm and permits families to pursue justice when a provider fails to meet the accepted standard of care.

Walgreens Accused of Filling Millions of Illegitimate Prescriptions in Federal Lawsuit

March 31, 2025 | Lebowitz & Mzhen

The U.S. Justice Department has filed a lawsuit against Walgreens, alleging the pharmacy chain played a direct role in fueling the opioid crisis by filling millions of unlawful prescriptions over the last decade. The complaint, filed in the U.S. District Court for the Northern District of Illinois, claims Walgreens pharmacists repeatedly dispensed controlled substances without verifying their legitimacy, allowing massive quantities of opioids and other drugs to flow through its stores unchecked. The allegations include violations of the Controlled Substances Act and the False Claims Act, underscoring the severity of the claims against one of the country’s largest pharmacy chains.

Federal prosecutors argue that Walgreens ignored red flags signaling fraudulent prescriptions and pressured its pharmacists to prioritize speed over proper scrutiny. The company allegedly discouraged internal communication among pharmacy staff, preventing pharmacists from warning each other about high-risk prescribers. Internal data, which should have revealed patterns of abuse, was also reportedly disregarded. The lawsuit contends that Walgreens actively created an environment where pharmacists lacked the resources and authority to intervene, even when they suspected illegal activity.

Has Walgreens Played a Role in the Opoiod Crisis?

Opioid addiction has devastated communities across the country, and pharmacies are supposed to act as a safeguard against improper distribution. Instead, the Justice Department claims Walgreens became a key link in a broken system, allowing opioids to be dispensed in excessive amounts with little oversight. According to the complaint, the company filled prescriptions that were blatantly unlawful, ignored concerns raised by its own pharmacists, and continued processing opioid orders despite clear signs of abuse.

AI-Enabled Wearables May Help Pharmacists Detect Medication Errors

November 30, 2024 | Lebowitz & Mzhen

The integration of artificial intelligence (AI) into healthcare continues to revolutionize patient safety, particularly in preventing medication errors. According to a recent report from TechTarget Health IT, researchers have developed an AI-enabled wearable device that monitors patients and identifies medication errors in real-time. This cutting-edge technology not only enhances patient safety but also highlights the ongoing challenges and risks associated with medication errors.

For patients who suffer harm due to medication mistakes, these innovations may provide an additional layer of protection. However, even the most advanced technology cannot replace the need for accountability when errors occur. In such cases, pharmacy error attorneys play a critical role in helping victims seek justice and compensation.

The Role of AI in Medication Safety

FDA Warns of Compounding and Dosing Errors with Injectable Semaglutide Products

October 30, 2024 | Lebowitz & Mzhen

The United States has become increasingly heavier over the past half century — overall obesity rates have increased three-fold since the 1960s. Currently, more than two-thirds of U.S. residents are now, by definition, overweight with those individuals qualifying as obese making up more than 40 percent of the population. Even more disturbing is the fact that one in ten individuals meet the medical criteria for a person who is morbidly obese, which can be a life-threatening condition if not counteracted by a change of diet and exercise.

Sadly, this increase in national obesity hasn’t happened overnight; in fact, it’s been a gradual and relentless process that has seen the number of overweight individuals in this country tripling over the past 60 years. Furthermore, the incidence of severe (morbid) obesity has increased ten-fold since the 1960s, and shockingly the figures may actually be an underestimation of this nationwide problem. Here in Maryland, the obesity rate is slightly below the national average at 34.3 percent as of 2021, but that is hardly any consolation.

With such a large number of overweight individuals in the U.S., dieting and nutritional advice has become big business over the past several decades. So many people, hoping to shed excessive weight quickly and with less effort, have fueled an entire industry of weight loss programs, supplements and prescription drugs. Enter Semaglutide, an FDA-approved pharmaceutical marketed by Novo Nordisk under several different brand names, which is being used to help patients with Type 2 diabetes and chronic obesity. This latest answer to the country’s obesity epidemic has shown great promise since its introduction several years ago, but as with many medications there are potential pitfalls and dangers facing those who take advantage of this breakthrough drug.

When States Step In: Pharmacies Sanctioned by Board of Pharmacies for Prescription Errors

April 26, 2023 | Lebowitz & Mzhen

A recent news report details just how troublesome prescription errors by pharmacies can be, resulting in sanctions. In the state of Iowa, state regulators recently penalized a drugstore accused of destroying relevant paperwork after dispensing the incorrect medication to a customer. According to the Iowa Board of Pharmacy, in 2020 the Walgreen store dispensed the incorrect strength of insulin pens and the incorrect test strips to a patient. During an investigation the Walgreens was unable to provide some of the original documentation related to the prescription. It was determined that the prescription records had been destroyed, which is in violation of Iowa regulations. As a result, the Board of Pharmacy issued a warning and imposed a $1,500 civil penalty, in addition to requiring the store to provide two hours of educational training on patient safety to all permanent pharmacists and technicians on staff. In addition to the one Walgreens being sanctioned, at least one other pharmacy in Iowa was sanctioned for dispensing a prescription with incorrect directions which led to a customer taking a higher dosage than was prescribed. In one case, a pharmacist’s license was placed on probation after a criminal conviction.

How Does Maryland Protect Pharmacy Patients?

Pharmacy boards are administrative agencies created by state governments “to protect the health, welfare, and safety of the public through the regulation of pharmacy practice.” In large part, these entities are responsible for preventing pharmacy errors. State pharmacy boards have taken important steps to regulate and discipline pharmacies and drug laws. For example, in the state of Maryland, the Maryland Board of Pharmacy has a mission of “protect[ing] Maryland consumers and to promote quality healthcare in the field of pharmacy through licensing pharmacists and registering pharmacy technicians, issuing permits to pharmacies and distributors, setting pharmacy practice standards and through developing and enforcing regulations and legislation, resolving complaints, and educating the public.” Guidance by the Office of Inspector General in the United States Department of Health and Human Services outlines that state pharmacy boards should review the outcomes of their disciplinary process and evaluate whether they are affording the public the maximum protection.

While state pharmacy boards play an important role in regulating and disciplining pharmacies and helping protect patients, in some prescription error incidents, victims or the loved ones of victims may consider filing a lawsuit to recover damages. These suits can be complex as you navigate the laws and court system, but connecting with an experienced attorney who can help you navigate your case can be beneficial.

Using Digital Solutions to Prevent Medication Error

January 21, 2023 | Lebowitz & Mzhen

Medication error has been a leading cause of harm for patients, and an expensive cost for healthcare providers. In a digital age, some healthcare providers have implemented digital solutions to medication errors, but these digital solutions can cause doctors to receive too many alerts that lack specificity and that also cause alert fatigue for doctors. However, when science and technology combine to create a unified and efficient approach for drug administration and managing clinical decisions, it can be life-altering. A Healthcare IT News article details the importance of hospitals integrating precision medicine with digital maturity models. The digital maturity models can help technology advances that support clinical decisions. This can help prevent errors and increase efficiency, which thus can save lives and costs for hospitals. Giving users access to a single information source in a unified approach can help with drug administration and minimize alerts.

What Is a Digital Maturity Model?

Some examples of digital maturity models include from Wolters Kluwer, which built Medi-Span Clinical APIs drug data solution and expert services which helps ensure that accurate information is available at key moments rather than reported after the event, and also ensures the precision of alerts. Another example is the National Chen Kung University Hospital in Taiwan, which has used Medi-Span Clinical APIs to overcome challenges faced by pharmacists, including the challenge of the amount of time it takes to update a medication database. Medi-Span’s databases are updated regularly with best practice evidence and recommendations. Clinical APIs are for healthcare professionals only, and there are certain regulations that guide their use in various locations.

The hospital’s data shows that since implementing Medi-Span, the number of alerts has been reduced by 21% and the talerts have captured severe potential Adverse Drug Events. This resulted in saving approximately $39,200 in U.S. dollars a year, and also saved an estimated 266 bed days a year. Technology advances can allow for solutions that help prevent medication errors and help ensure that patients receive the best and safest care possible. When these errors occur but can be avoided by digital maturity, it is up to hospitals to implement unified approaches to avoid such costs.

New Best Practices Released for Ensuring Medication Safety

September 29, 2022 | Lebowitz & Mzhen

People that regularly take prescription medicine or have received prescription medication in a hospital or clinic setting can appreciate the vital importance of best practices when it comes to receiving medicine. Whether it is at the pharmacy or in the hospital, it is essential to be aware of safety measures that could make a major difference in the care you receive. Every patient deserves peace of mind when it comes to their medications, and to live free of the consequences of medical and pharmaceutical malpractice.

How Common Are Medication Mistakes?

Incorrect or erroneous distribution or application of medications is surprisingly present in the United States. In fact, some sources cite a rate of one in five Americans experiencing a medical error while receiving health treatment. Unfortunately, Maryland is no exception to this trend, and Maryland residents should be aware of emerging best practices in the face of the increased computerization of pharmacies and hospital medication cabinets.

Emerging Best Practices to Reduce Harm

Employee Shortage May Result in More Maryland Pharmacy Errors

December 31, 2021 | Lebowitz & Mzhen

COVID-19 has made an indelible impact on almost every aspect of a person’s life, and while there is hope on the horizon, the effects continue to reverberate. One significant impact is the ongoing staff and supply shortages at many pharmacies. Pharmaceutical shortages can be deadly to some consumers, but employee shortages can also result in Maryland pharmacy errors. A recent piece from NBC highlighted how these shortages impact the health of those throughout the country.

Pharmacy technicians primarily work in retail pharmacies and hospital pharmacies. Pharmacies are reporting that many of their technicians are leaving in droves because of the increasing demand. The majority of the workers behind a pharmacy counter are pharmacy technicians. These positions are often low-wage and do not require an advanced degree. Technicians are responsible for counting pills, filling prescriptions, and checking inventory. All of these duties are fundamentally important to ensuring consumer safety.

Although many understand that working in a pharmacy is inherently fast-paced, many technicians argue that the wage has not kept up with the workload. Most importantly, workers explained that the demands led to safety issues for consumers. Workers expressed that the stresses and influx of work made them far more likely to make mistakes or catch errors. These errors can have life-threatening and deadly consequences for those who rely on pharmacists and technicians for their medication.

Understaffing at Pharmacies May Affect Maryland Patients

November 11, 2021 | Lebowitz & Mzhen

When customers pick up medicine at the pharmacy, they should have a reasonable expectation that the pharmacists dispensing your prescription are well trained, proactive, and detail-oriented so that your medication is filled properly and correctly. What happens, however, when pharmacies are unable to provide patients with the high-quality care they deserve and wrong medications or doses put patients at risk for injury or death?

According to a recent news report, understaffing at various pharmacies has placed various patients at risk and has raised concerns about patient safety. After a pharmacist at a particular pharmacy gave a patient a hundred extra doses of a powerful prescription opioid and gave another patient an antibiotic that landed them in the hospital because of a known allergic reaction, there has been increased scrutiny on chronic understaffing and unsustainable workloads prevalent in pharmacies. One pharmacy chain, in particular, received a $427,000 fine after an investigation found that basic protocols were not being followed.

Because pharmacies, especially those that operate at high volume locations, are responsible for filling anywhere between 500 to 1,000 prescriptions a day, can receive upwards of ten phone calls at a time, and operate drive-thrus and in-store services such as medication counseling and flu vaccines, many pharmacists and technicians report being overworked and under-supported, leading to mistakes.

Lack of Medication Instructions Presents Serious Risks for Maryland Patients

September 16, 2021 | Lebowitz & Mzhen

Medications not only have to be safe but also must contain sufficient warnings and instructions so that patients will know how to use them safely. A medication’s lack of clear instructions and warnings puts patients at risk. A plaintiff may bring a Maryland pharmacy claim against a drug manufacturer for failing to warn of the dangers of taking a medication.

Do Drug Manufacturers Need to Put Warnings on Dangerous Drugs?

Unless a danger is obvious and widely known, a medication must provide adequate warnings concerning the medication’s risks, such as known side effects. Warnings must also be clear and easy to understand. The medication also must include adequate instructions on how to take the medication safely. Courts will consider the knowledge and expertise of the average consumer that uses the medication. If a medication’s instructions are not clear enough or do not contain sufficient information so that consumers will know how to safely use the medication, the instructions are not sufficient, and the manufacturer may be liable for injuries that occur as a result.